HOME >> MEDICINE >> NEWS
Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration

NEW ORLEANS, October 21, 2004 -- Eyetech Pharmaceuticals, Inc. (Nasdaq: EYET) today announced that the treatment effect with the investigational drug Macugen (pegaptanib sodium injection) extends for two years in patients with neovascular or wet, age-related macular degeneration (AMD), who are at risk of losing their vision. A treatment benefit was also seen for patients who received Macugen for two years compared to those only receiving one year of therapy.

The data confirm that patients benefit from two years of treatment with Macugen for wet AMD. The second year data for Macugen will be presented by Anthony P. Adamis, M.D., Chief Scientific Officer, Eyetech Pharmaceuticals and Steven Schwartz, M.D., Chief, Retina Division, Jules Stein Eye Institute, University of California, Los Angeles, at the Retina Subspecialty symposium of the American Academy of Ophthalmology Meeting on Friday, October 22, 2004 at 8:00 a.m. Central Time and 10:38 a.m. Central Time respectively.

Eyetech and Pfizer are partnering to develop and market Macugen, a treatment for neovascular or wet AMD, the leading cause of severe vision loss in patients older than 50 years of age in the developed world. Eyetech and Pfizer have filed an NDA for Macugen for neovascular AMD with the FDA. Macugen has been assigned priority review status and the PDUFA date is December 17, 2004.

"We are excited about the new data because they confirm that treatment with Macugen is effective in patients with neovascular AMD who are at risk of losing their vision," said David R. Guyer, M.D., Chief Executive Officer, Eyetech Pharmaceuticals. "The two year data on Macugen demonstrate that longer term use may be beneficial for patients suffering from this chronic disease."

These data are from two, pivotal Phase II/III randomized, multi-center, double-masked studies in patients with all subtypes of neovascular AMD. 1,186 patients were initially randomized to receive one
'"/>


21-Oct-2004


Page: 1 2 3

Related medicine news :

1. The Gerontological Society of America announces Hartford Fellowship recipients
2. TB Alliance announces new drug discovery program with GlaxoSmithKline
3. ASGE announces grant recipients in annual research awards program
4. Novartis announces collaboration with Bayer for EMSELEX
5. American College of Chest Physicians announces new Critical Care Institute
6. Department of Energy announces new agreement with USC, national labs and private company
7. ACP announces international medical fellowship
8. St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study
9. St. Jude Medical announces PAVE and DINAMIT clinical trial results
10. National Inventors Hall of Fame announces 2004 class of inventors
11. Joslin announces first international affiliate in Bahrain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 05, 2018 , ... Marking its seventh year, ... global celebration “A Toast Heard ‘Round the World” on New Year’s Eve. Each ... school’s global community (alumni, students, faculty members, staff, families, and friends of the institution) ...
(Date:12/5/2018)... , ... December 05, 2018 , ... Northcentral University (NCU) ... of nursing. Available starting today and on a weekly rolling basis to registered nurses, ... Nursing Practice in Executive Leadership (DNP) will prepare degree candidates to become leaders ...
(Date:12/5/2018)... Calif. (PRWEB) , ... December 05, 2018 , ... ... This philosophy reinforces the theme of Unitek’s transformative conference at the DoubleTree Hilton ... AHN-BC, FAAN, LL (AAN), Distinguished Professor and Founder/Director of Watson Caring Science Institute, ...
(Date:11/29/2018)... , ... November 29, 2018 , ... “The total demand ... Tice, Senior Vice President of Business Intelligence at SDi. “We project the market will ... by increasing demand for novel drugs as the global population ages.” , This report ...
(Date:11/28/2018)... ... 2018 , ... CBD merchants throughout the United States and ... merchants were unable to obtain legitimate CBD processing accounts without being labeled a ... business after being put on the Visa and Mastercard processing blacklist. CBD merchants ...
Breaking Medicine News(10 mins):
(Date:11/28/2018)... OKLAHOMA CITY (PRWEB) , ... November 28, 2018 , ... ... to high levels of myopia and astigmatism in one easy procedure following FDA approval ... using the Toric ICL, is scheduled at nJoy Vision OKC on November 29th by ...
(Date:11/28/2018)... ... November 28, 2018 , ... Shady Grove ... Monica Best, M.D. has joined the practice’s award-winning Atlanta medical team. Dr. ... their most recent addition, Natalie Stentz. Dr. Best is currently accepting new patients ...
(Date:11/28/2018)... ... November 28, 2018 , ... On Friday, Nov. 16, 2018 ... and West Virginia (SimPOW) at their corporate headquarters in Monaca. , Attendees celebrated ... Bargerstock were recognized in the opening session. Attendees enjoyed a commemorative cake. Pocket ...
Breaking Medicine Technology:
Cached News: